Literature DB >> 30003705

Blood pressure measurement in special populations and circumstances.

George S Stergiou1, Eamon Dolan2, Anastasios Kollias1, Neil R Poulter3, Andrew Shennan4, Jan A Staessen5,6, Zhen-Yu Zhang5, Michael A Weber7.   

Abstract

According to the established validation protocols, a typical validation study of a blood pressure (BP) monitor includes general population adults with normal or elevated BP. It is recognized, however, that the automated (oscillometric) BP monitors may have different accuracy or uses in some special populations compared with adults in the general population. Thus, an automated BP monitor with proven accuracy in a general population of adults may not be accurate in a special population, and therefore separate validation is needed. Recognized special populations deserving separate validation are those for which there is theoretical, and also clinical evidence, that the accuracy of BP monitors in these groups differs from that in the general population. Young children, pregnant women (including those with preeclampsia), individuals with arm circumference >42 cm, and patients with atrial fibrillation are regarded as special populations. Adolescents, individuals older than 80 years, and patients with end-stage renal disease or diabetes mellitus have also been considered as possible special groups, but there is still inadequate evidence of altered accuracy of BP monitors in these subjects. Validation studies should be performed in special populations and evaluated separately after the BP-measuring device has successfully undergone a validation study in a general population (unless the test device is intended only for a special population). This article discusses issues relating to the measurement of BP and the diagnosis of hypertension in selected special populations, as well as in low-resource settings, where a simplified yet efficient evaluation strategy is necessary. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  accuracy; atrial fibrillation; blood pressure measurement; children; pregnancy

Mesh:

Year:  2018        PMID: 30003705      PMCID: PMC8030798          DOI: 10.1111/jch.13296

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  44 in total

1.  Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions.

Authors:  Elke Wühl; Klaus Witte; Marianne Soergel; Otto Mehls; Franz Schaefer
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

2.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

3.  Measuring blood pressure in the elderly: does atrial fibrillation increase observer variability?

Authors:  D Sykes; R Dewar; K Mohanaruban; K Donovan; F Nicklason; D M Thomas; D Fisher
Journal:  BMJ       Date:  1990-01-20

Review 4.  Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis.

Authors:  George S Stergiou; Anastasios Kollias; Antonios Destounis; Dimitrios Tzamouranis
Journal:  J Hypertens       Date:  2012-11       Impact factor: 4.844

5.  Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.

Authors:  Joseph T Flynn; David C Kaelber; Carissa M Baker-Smith; Douglas Blowey; Aaron E Carroll; Stephen R Daniels; Sarah D de Ferranti; Janis M Dionne; Bonita Falkner; Susan K Flinn; Samuel S Gidding; Celeste Goodwin; Michael G Leu; Makia E Powers; Corinna Rea; Joshua Samuels; Madeline Simasek; Vidhu V Thaker; Elaine M Urbina
Journal:  Pediatrics       Date:  2017-08-21       Impact factor: 7.124

Review 6.  Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations.

Authors:  Willem J Verberk; Stefano Omboni; Anastasios Kollias; George S Stergiou
Journal:  Int J Cardiol       Date:  2015-10-26       Impact factor: 4.164

7.  Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial.

Authors:  Raghupathy Anchala; Stephen Kaptoge; Hira Pant; Emanuele Di Angelantonio; Oscar H Franco; D Prabhakaran
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

8.  Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: A prospective cohort study.

Authors:  Hannah L Nathan; Paul T Seed; Natasha L Hezelgrave; Annemarie De Greeff; Elodie Lawley; John Anthony; David R Hall; Wilhelm Steyn; Lucy C Chappell; Andrew H Shennan
Journal:  Pregnancy Hypertens       Date:  2017-11-21       Impact factor: 2.899

Review 9.  A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

Authors:  George S Stergiou; Bruce Alpert; Stephan Mieke; Roland Asmar; Neil Atkins; Siegfried Eckert; Gerhard Frick; Bruce Friedman; Thomas Graßl; Tsutomu Ichikawa; John P Ioannidis; Peter Lacy; Richard McManus; Alan Murray; Martin Myers; Paolo Palatini; Gianfranco Parati; David Quinn; Josh Sarkis; Andrew Shennan; Takashi Usuda; Jiguang Wang; Colin O Wu; Eoin O'Brien
Journal:  Hypertension       Date:  2018-01-31       Impact factor: 10.190

Review 10.  The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis.

Authors:  Caroline Free; Gemma Phillips; Louise Watson; Leandro Galli; Lambert Felix; Phil Edwards; Vikram Patel; Andy Haines
Journal:  PLoS Med       Date:  2013-01-15       Impact factor: 11.069

View more
  6 in total

Review 1.  Automated Office-Based Blood Pressure Measurement: an Overview and Guidance for Implementation in Primary Care.

Authors:  Romsai T Boonyasai; Erika L McCannon; Joseph E Landavaso
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

Review 2.  Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period.

Authors:  Natalie A Bello; Eliza Miller; Kirsten Cleary; Ronald Wapner; Daichi Shimbo; Alan T Tita
Journal:  Curr Hypertens Rep       Date:  2018-10-25       Impact factor: 5.369

3.  Achieving reliable blood pressure measurements in clinical practice: It's time to meet the challenge.

Authors:  Eoin O'Brien; Eamon Dolan; George S Stergiou
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

4.  Accuracy of automated blood pressure measurements in the presence of atrial fibrillation: systematic review and meta-analysis.

Authors:  Christopher E Clark; Sinead T J McDonagh; Richard J McManus
Journal:  J Hum Hypertens       Date:  2019-01-10       Impact factor: 3.012

Review 5.  A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics).

Authors:  Liona C Poon; Laura A Magee; Stefan Verlohren; Andrew Shennan; Peter von Dadelszen; Eyal Sheiner; Eran Hadar; Gerard Visser; Fabricio Da Silva Costa; Anil Kapur; Fionnuala McAuliffe; Amala Nazareth; Muna Tahlak; Anne B Kihara; Hema Divakar; H David McIntyre; Vincenzo Berghella; Huixia Yang; Roberto Romero; Kypros H Nicolaides; Nir Melamed; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-07       Impact factor: 4.447

6.  Blood pressure measurement in special populations and circumstances.

Authors:  George S Stergiou; Eamon Dolan; Anastasios Kollias; Neil R Poulter; Andrew Shennan; Jan A Staessen; Zhen-Yu Zhang; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.